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1. Introduction  
The worldwide epidemic of Type 2 Diabetes Mellitus, a result of recent deep changes in 
human lifestyle like sedentary and overly rich nutrition, has dramatic consequences in terms 
of morbidity, mortality and health care costs (Zimmet et al., 2001). Type 2 Diabetes Mellitus 
is a complex and multifactorial metabolic disorder which includes distinct nosological 
entities whose common patterns are hyperglycaemia, resistance to insulin and progressive 
chronic complications (American Diabetic Association, 2009). 
A significant proportion of patients will develop a clinically relevant diabetic nephropathy 
with glomerulopathy, hyalinization of afferent and efferent arterioles, tubular and 
interstitial lesions (Fioretto et al., 2008). Nephropathy is a very serious complication in both 
Type 1 and Type 2 Diabetes Mellitus because patients with diabetic kidney disease are at a 
higher risk of mortality, mostly from cardiovascular complications, than diabetic patients 
without diabetic nephropathy (Dronavalli & Barkis, 2008).  
In the Western World the incidence of end-stage renal failure associated to the burden of 
diabetic nephropathy has increased in recent years and represents a failure of current 
disease control measure with serious public health implications (Stewart et al, 2006; Villar & 
Zaoui, 2010). In Latin America, where incidence of Type 2 Diabetes Mellitus is on the rise 
and has reached epidemic proportions, people usually have poor disease control with the 
consequence of very high rates of diabetic nephropathy (Caballero & Tenzer, 2007). A study 
performed in the Asian Pacific region has also shown that diabetic nephropathy was the 
most common cause of End-Stage Renal Disease in 9 of the 12 countries surveyed and 6 of 
the 12 countries had greater than 35% of their dialysis patients age 60 years and older (Lee, 
2003). In United States, between 20% and 40% of patients ultimately develop diabetic 
nephropathy, the most common cause of End-Stage Renal Disease requiring dialysis 
(Dronavalli & Barkis, 2008). Since 2000, the adjusted rate of prevalent End-Stage Renal 
Disease cases in the United States population ages 65–74, has increased 25 % with an 
enormous economic impact on the healthcare systems (United States Renal Data System, 
2010). In sum, worldwide incidence of diabetic nephropathy, a frequently silent and 
unrecognized disease, has increased about a 50% between 1998 and 2008 and is now the 
leading cause of chronic kidney disease and End-Stage Renal Disease (Unites States Renal 
www.intechopen.com
Recent Advances in the Pathogenesis, Prevention and  
Management of Type 2 Diabetes and its Complications 
 
284 
Data System, 2008). These epidemiological findings along with the several pathways which 
have been implicated in the progression of diabetic nephropathy, such as systemic and 
glomerular hypertension, metabolic derangements (hyperglycaemia, hyperlipidaemia, 
hyperinsulinaemia), and oxidative stress among others, indicate the complexity and the 
magnitude of diabetic nephropathy as a health concern. 
Streptozotocin-induced pancreatic injury as well as uninephrectomy have been used for 
creating both rat and mouse models of Type 1 Diabetes Mellitus which develop renal injury 
with similarities to human diabetic nephropathy (Tesch & Allen., 2007). Nephropathy is also 
a complication in rat models of spontaneous Type 2 Diabetes Mellitus as the obese Zucker 
(fatty) rat, the Goto Kakizaki rat (Janssen et al., 1999) and the hypertensive/NIH-corpulent 
rat (Nangaku et al., 2005) and in mice models as the BTBR Ob/Ob mutant mice (Hudkins et 
al., 2010). Either spontaneous or induced, rodent models of diabetes have been extensively 
used in diabetes research because of their usefulness for understanding the pathogenesis, 
the complications and the genetic or environmental influences that increase the risks of 
suffering Type 2 Diabetes Mellitus (Srinivasan & Ramarao, 2007). These models, which 
depict many clinical features or related phenotypes of the disease, differ among them not 
only in its metabolic alterations but in their etiopathogenia (Breyer et al. 2005; 
Chatzigeorgiou et al., 2009). Although their use has allowed important advances toward the 
better understanding of human diabetic nephropathy, it has been recently pointed out that a 
lack of reliable animal models of diabetic complications still persists (Brosius et al., 2009). 
The eSS rat is a spontaneously non-obese diabetic model obtained in Rosario, Argentina, by 
genetic manipulation, described in detail by Martinez et al. (1993). eSS rats evidence a 
progressive impaired glucose tolerance from 70 days of age onwards with hyperglycaemia 
and glycosuria worsening with ageing, being these signs much more striking in males 
(Martínez et al., 1988). Males exhibit insulin resistance and consequent insulin 
hypersecretion till 12 months of age but the hormone secretion decreases as diabetes 
progresses in the sequence of events from insulin resistance to overt diabetes (Martínez et 
al., 1988). This finding is coincident with conspicuous changes in the pancreas of 18 month-
old eSS males, such as disruption of islet architecture and areas of pronounced fibrosis 
(Tarrés et al., 1992; Picena et al., 2007).  
During the second year of life, eSS males are known to develop glomerulosclerosis and 
tubular nephrosis similar to those found in long-term human diabetes (Tarrés et al., 1992; 
Martínez et al., 1993). Older eSS males also develop bilateral cataracts but not retinopathy 
(Tarrés et al., 1990; Picena et al., 2005). Hence, the eSS rat was proposed as a model of non-
insulin dependent diabetes characterized by complex glucose and lipid disorders (Martínez 
et al., 1993; Montanaro et al., 2003; Daniele et al., 2010).    
eSMT rats (IIMe/Fm eSMT) derived from crossing eSS with ß rats, both parent strains 
belonging to the IIM stock (Calderari et al., 1991).  ß (IIMb/Fm ß) is a line of moderately and 
spontaneous obese, fertile and hypertriglyceridemic rats (Calderari et al., 1987; Hisano et al., 
1994). Upon crossing the F1 to obtain F2, the new colony eSMT was maintained as a closed 
one, where the full genetic history of each breeding rat is preserved (Tarrés et al., 2000). 
Young eSMT animals are more robust than eSS and develop higher levels of fasting 
hyperglycaemia, glycosuria, glucose intolerance, blood triglycerides and total cholesterol 
(Tarrés et al., 2000; Montenegro et al., 2005). eSMT males of 6 and 9 months show islets with 
altered shapes and fibrosis, as well as sporadic images of apoptosis and at 12 months of age, 
islets are reduced in number and size, resembling the histoarchitecture of eSS males during 
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their second year of life (Tarrés et al., 2000). The sexual dimorphism is less evident in eSMT 
than in eSS diabetic syndrome (Picena, 2007).   
The aim of this chapter is to present a wide and diachronic study of renal histopathology in 
eSS and eSMT rats, two strains which develop hereditary type 2 diabetic syndromes with 
different expression of the metabolic disorders, in order to characterize morphological 
changes. The arrival to conclusions could improve our knowledge and understanding of 
diabetic nephropathy.  
2. Material and methods  
The study was conducted in highly inbred 139 eSS (males= 71; females= 68) and 122 eSMT 
(males= 50; females= 72) rats from 3 to 26-30 months of age.  Eumetabolic Wistar male rats 
of 12 (n= 15) and 21 month-old (n=12) were used as controls. 
Since the expected life span of the eSS and the eSMT rats in our laboratory ranges from 24-30 
months, the morphological studies of diabetic nephropathy covered their entire life span.  
From 3 months of age onwards, groups of rats from eSS and eSMT strains were euthanized. 
Previously, glycaemia at 120 min after 10% glucose overload (200 mg/100 g body weight) 
via stomach tube was assessed. Blood samples were obtained by tail vein puncture. Plasma 
samples were analysed for glucose by the glucose oxidase enzymatic method using a 
commercial kit (Wiener Laboratories, Argentina).  
Body and kidney weights were registered in every case. Sections of renal tissue were fixed 
in 10% neutral-buffered formalin for 24 hours, embedded in paraffin, cut into sections of 4 
µm thick, stained with hematoxylin-eosin (HE) and Periodic Acid-Schiff (PAS), and 
examined by light microscopy in a blinded fashion. In each histological specimen, capsular 
and glomerular diameters of 10 superficial and 10 juxtamedullary nephrons, cut at the 
vascular pole, were measured through a calibrated Shimadzu ® linear scale, placed in the 
eyepiece of a light microscopy. Correlations between age and body weights, and age and 
kidney weights were also performed.  
Glomeruli were classified as small when the diameter was lower than 80μm. Mesangial 
expansion, defined as the thickening mesangium by the deposit of an acidophilic, 
amorphous, PAS positive matrix substance and by the increase of cellular components, was 
considered diffuse when the glomerulus was wholly affected, and segmental if it was 
partially affected. Depending on its severity, it was graded as mild (ME +) or severe (SE ++). 
Fifty glomeruli per kidney were randomly selected in each animal. Percentages (%) of 
glomeruli displaying the same degree of injury (small glomeruli, ME+ and SE ++) were 
obtained per animal. Correlations between age and percentage of small glomeruli, and age 
and mildly and severely affected glomeruli were calculated. Nodular increases in mesangial 
matrix as well as the presence of sclerotic or atubular glomeruli and capsular drop were also 
sought for. Tubulointerstitial and vascular injuries were considered on the basis of tubular 
dilation and atrophy, interstitial infiltration and fibrosis as well as of intimal thickening and 
arteriolar hyalinosis, respectively. 
eSS rats were maintained in the breeding facilities of our School of Medicine, Rosario 
University, Rosario, Argentina. Wistar rats came from the animal breeding facilities in the 
School of Biochemical Science, Rosario University. Breeding conditions were the same for all 
the animals, including temperature regulation (24ºC) and light-darkness cycles as well as the 
artificial air exchange. In all the cases, the individuals had remained housed since they were 
21 days old, in hanging collective cages. All animals were fed on a complete commercial 
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diet, special for laboratory rats, and water was ad libitum. These experimental conditions 
were maintained until the animals were euthanized.  
All data are reported as the mean ± standard deviation. Statistical processing was partly 
carried out with the software SPSS 15, using the parametric and non-parametric methods 
referred below in the presentation of results. 
All experimental procedures presented in this study were previously approved by the 
Bioethics Commission of School of Medicine, which assures adherence to the standards by 
the Guide for the Care and Use of Laboratory Animals. 
3. Results  
Body weights data in the experimental eSS and eSMT animals are seen in Table 1. 
 
Age 
(months) 
Line eSS Line eSMT Anova 
(effect: p) Males Females Males Females 
3 
266±21  
(n=6) 
137±14 
(n=9) 
300±43 
(n=11) 
207±13 
(n=9) 
Line:0.015 
Sex:0.000 
Interaction:0.000 
6 
342±26 
(n=19) 
245±43 
(n=7) 
368±55  
(n=5) 
284±31 
(n=11) 
Line:0.016 
Sex:0.000 
Interaction:0.481 
9 
362±17 
(n=4) 
232±14 
(n=10 
397±61 
(n=12) 
308±40 
(n=6) 
Line: 0.004 
Sex: 0.000 
Interaction: 0.154 
12 
389±23 
(n=14) 
252±16 
(n= 6) 
419±61  
(n=6) 
338±34 
(n=11) 
Line:0.002 
Sex:0.000 
Interaction:0.215 
15 
399±72 
 (n=9) 
337±15 
(n=6) 
431±91 
 (n=5) 
370±42 
(n=7) 
Line:0.051 
Sex:0.054 
Interaction:0.889 
18 
402±51 
(n=14) 
345±36 
(n=12) 
416±47 
 (n=8) 
350±35 
(n=13) 
Line:0.440 
Sex:0.000 
Interaction:0.031 
21 
357±40 
(n=11) 
338±26 
(n=12) 
378±36  
(n=8) 
348±58 
(n=12) 
Line:0.063 
Sex:0.001 
Interaction:0.055 
24 
282±25 
 (n=5) 
254±52 
(n=11) 
297±61  
(n=4) 
319±57 
(n=15) 
Line:0.087 
Sex:0.099 
Interaction:0.034 
≥ 26  242±26 
(n=7) 
 
313±37  
(n=4) 
Line:0.001 
Values expressed as mean ± standard deviation.  
Table 1. Body weights (g) in male and female eSS and eSMT rats from 3 to ≥26 months of age. 
There was a significant line effect on body weight being eSMT heavier than eSS. A sex-
dependent effect was also demonstrated remaining the males heavier than the females. 
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Table 1 also indicates that body weight increased in male and in female eSS rats till 18 
months of age whilst eSMT rats underwent a similar evolution up to 15 months of age.  
Body weight was significantly correlated with age in both lines (eSS: r=0.171; p=0.050; 
eSMT: r=0.218; p=0.016). The low values obtained could be owed to the marked declination 
of body weight in the older animals.  
As shown in Table 2, kidney weights increased up to 18 months of age in eSS males and till 
15 months of age in eSMT males being always greater in eSMT rats than in eSS rats and in 
males than in females. 
 
Age 
(months) 
Line eSS Line eSMT Anova 
(effect: p) Males Females Males Females 
3 2.30±027 1.25±0.25 2.40±0.22 1.94±0.24 
Line:0.005 
Sex:0.000 
Interaction:0.050 
6 2.79±0.32 2.03±0.15 2.84±0.45 2.40±0.19 
Line:0.007 
Sex::0.000 
Interaction:0.022 
9 3.55±0.38 2.26±0.16 3.70±0.31 2.55±0.38 
Line:0.041 
Sex:0.000 
Interaction:0.041 
12 3.15±0.63 2.63±0.10 4.02±0.94 2.97±0.29 
Line: 0.004 
Sex: 0.000 
Interaction:0.001 
15 3.85±0.52 2.75±0.26 4.68±0.36 3.22±0.28 
Line:0.952 
Sex:0.000 
Interaction:0.027 
18 4.06±0.57 2.87±0.45 4.39±0.55 3.20±0.44 
Line:0.000 
Sex:0.000 
Interaction:0.026 
21 3.68 ± 1.14 2.82±0.35 3.99±0.49 3.17±0.21 
Line:0.546 
Sex:0.014 
Interaction:0.221 
24 3.21 ± 1.13 2.78±0.43 3.88±0.46 3.12±0.37 
Line:0.546 
Sex:0.014 
Interaction:0.032 
≥ 26  2.67±0.27  3.01±0.10 Line:0.001 
 Values expressed as mean ± standard deviation 
Table 2. Kidney weights (g) in male and female eSS and eSMT rats from 3 to ≥26 months of 
age 
Direct and significant correlations were demonstrated between kidney weight and age in 
eSS and eSMT lines (eSS: r=0.324; p=0.000; eSMT: r=0.498; p=0.000).  
Line and sex effects were shown on glucose tolerance being glycaemia after 120min glucose 
overload (G120)  higher in eSMT rats than in eSS rats and in males than in females. A 
noticeable worsening of G120 with ageing was also evident (Table 3).  eSS males reached the 
G120 threshold for diagnosis of overt diabetes (G120≥200 mg/dl) from 6 months of age 
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onwards and eSMT males, from 3 months of age. Females displayed similar values later (eSS 
from 12 months of age and eSMT from 9 m months of age). Wistar rats did not show any 
significant age-dependent changes remaining normoglycemic until 21 months of age (G120: 
109 ± 10 mg/dl). 
 
Age 
(months) 
Line eSS Line eSMT Anova 
(effect: p) Males Females Males Females 
3 168±37 124±08 201±75 132±20 
Line:0.000 
Sex:0.012 
Interaction:0.330 
6 237±44 179±39 264±41 187±28 
Line:0.018 
Sex:0.034 
Interaction:0.342 
9 254±43 188±27 303±34 207±35 
Line:0.016 
Sex:0.002 
Interaction:0.431 
12 299±64 201±32 324±43 223±42 
Line:0.004 
Sex:0.000 
Interaction:0.154 
15 301±55 222±25 356±44 270±33 
Line:0.051 
Sex:0.054 
Interaction:0.889 
18 309±49 226±46 429±27 289±26 
Line:0.044 
Sex:0.000 
Interaction:0.330 
21 314±42 235±38 433±52 299±35 
Line:0.063 
Sex:0.001 
Interaction:0.752 
24 317±35 240±32 438±64 301±27 
Line:0.028 
Sex:0.029 
Interaction:0.349 
≥ 26  242±22  309±46 Line:0.001 
Values expressed as mean ± standard deviation 
Table 3. Glycaemia after 120min glucose overload (mg/dl) in male and female eSS and 
eSMT rats from 3 to ≥26 months of age. 
Present results indicate that at 3 month of age, when animals are still quite normoglycemic 
with the exception of eSMT males, kidneys did not show lesions visible under the light 
microscope and that renal injury became apparent from 6-month-old onward. The most 
frequent glomerular lesions were ME+ and SE++ diffuse mesangial expansion. Direct and 
significant correlations were evidenced between the percentage of diffuse mesangial 
expansion and the age (ME+: eSS ρ= 0.873; p= 0.000. eSMT ρ= 0.689; p= 0.000 and ME++: 
eSS ρ= 0.832; p= 0.000. eSMT ρ= 0.863; p= 0.000). Nevertheless, an increasing number of 
small glomeruli (> 80 µm) were also verified in ageing eSS and eSMT individuals (eSS ρ= 
0.774; p= 0.000; eSMT ρ= 0.641; p= 0.000). In 12 month-old eSS rats, the glomerular diameter 
was higher in females (♂: 110 ± 8 μm vs. ♀: 120 ± 6; p<0.01) whilst in eSMT strain these 
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values were not different between sexes (♂:102 ± 9 μm vs. ♀:106 ±11; p>0.05). eSMT females 
showed similar values of glomerular diameter to those registered in eSS males (eSS ♂: 110 ± 
8 μm eSMT vs. eSMT ♀: 106 ±11 ; p>0.05) . Significant correlations between the percentages 
of small glomeruli, glomeruli with ME+ and with SE++ and age are shown in Figure 1. 
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Fig. 1. Correlations between age and percentage of small glomeruli (eSS ρ= 0.774; p= 0.000; 
eSMT ρ= 0.641; p= 0.000), ME+ (eSS ρ= 0.873; p= 0.000. eSMT ρ= 0.689; p= 0.000), and ME++ 
(eSS ρ= 0.832; p= 0.000. eSMT ρ= 0.863; p= 0.000) in male (●) and female (●) eSS and eSMT rats.  
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In both lines, glomerular damage began with thickening of the basement membrane in the 
peripheral sector of the glomeruli, followed by segmentary or diffuse mesangial expansion 
due to the deposit of an acidophilic, amorphous, PAS-positive substance in addition to 
increased cellularity (Fig 2 A and 2 B). Progressively, eSMT y eSS males showed a rising 
number of small glomeruli (Fig 2 C). While glomerular histology by light microscopy was 
rather normal in eSS rats younger than 12 months of age, a mild PAS positive thickening of 
glomerular basement membrane was commonly detected in older males. Mild or severe 
mesangial expansion was usual in 21 month-old eSS males as well as basement membrane 
thickening. In eSMT rats, mild thickening of the basement membrane was detected from 6 
month-old males onwards, and worsened in older animals.  
 
A B
C D
E F
 
Fig. 2. (A) Mild diffuse mesangial thickening of the glomerular basement membrane (6-month-
old eSMT male); (B) Segmentary mesangial expansion with an eccentric area of tuft-to-capsule 
adhesion (18-month-old eSMT male); (C) Left: small glomerulus (18-month-old eSS male); (D) 
Glomerulus totally occluded by fibrohyalinosis (21-month-old eSMT male); (E) Glomerulus 
with severe mesangial expansion and areas of tuft-to-capsule adhesion. Lymphocytic 
infiltrates near the vascular pole and intertubular interstitium. Atrophic tubules are also 
observed (24-month-old eSMT male);  (F) Arrow: Kimmelstiel-Wilson-like nodular lesion (18-
month-old eSMT male). HE and Periodic acid-Schiff (PAS) stain. 300X, except F (400X). 
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Prominent diffuse or segmentary mesangial expansion and, occasionally, areas of tuft-to-
capsule adhesion were evident in the 12- and 18-month-old eSMT males. Severe injury was 
evidenced by many sclerotic glomeruli totally occluded (Fig 2 D) and a smaller number of 
atubular glomeruli with tuft adhesions in the older eSMT males (Fig 2 E). Prominent 
thickening of the peripheral glomerular basement membrane resulted in lobules with an 
abnormal architecture and a noticeable image of stiffness was observed in 60% of the eSMT 
rats and in 40% of the eSS after 21 months of age. Glomeruli with capsular drops or fibrin 
cap were not observed either in eSS or eSMT rats. A Kimmelstiel-Wilson-like nodular lesion 
was detected only in a 18-month-old eSMT male (Fig 2 F). Sporadically, periglomerular 
fibrosis was observed in eSMT and eSS females. 
 
A B
C D
E F
 
Fig. 3. (A) Intense lymphocytic infiltrate in renal pelvis (18-month-old eSMT female) (40X); 
(B) Mild tubular lesions (12-month-old eSS female) (300X); (C)  Moderate tubular lesions 
characterized by disgregation of epithelial cells (6-month-old eSMT male) (300X); (D) Group 
of mildly dilated tubules with lumina containing protein casts (12-month-old eSS male) 
(300X). (E)  Panoramic view of the renal medulla showing different tubular alterations, 
marked dilatation with protein content (15-month-old eSMT male) (100X); (F) Area of 
subcapsular retraction due to fibrosis. Parenchymal atrophy and lymphocytic infiltrates ( 24- 
month-old eSS male) (40X). HE and Periodic acid-Schiff (PAS) stain. 
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Areas of arteriolar hyalinosis and thickening of smooth muscle were observed in eSMT 
males from 9 months, in eSS males and eSMT females from 12 months and in eSS females 
from 21 month-old.  
A few focal interstitial and pyelic mononuclear cell aggregates (Fig 3 A), concomitant with a 
mild tubular disruption, were apparent in 6-month-old eSS and eSMT males (Fig 3 B and     
3 C). Groups of atrophic tubules with their lumina filled by hyaline casts were already 
noticeable in some 6-month-old eSS and eSMT males, progressing with ageing (Fig 3 D and 
3 E).  Prominent interstitial fibrosis and tubular atrophy and dilatation with vacuolization 
and desquamation of tubular cells, were observed in 100% of eSS and eSMT males at 18-24 
months of age and older; these features were also detected in some 12-month-old eSS and 
eSMT females, affecting 80% of 24-month-old individuals. In older animals, subcapsular 
chronic inflammatory infiltrates, tubular atrophy and fibrosis lead to navel-like retractions 
of the kidney surface (Fig 3 F).  
Renal damage, characterized by diffuse glomerulosclerosis and conspicuous tubular 
nephrosis, was registered in older eSMT and eSS males. Young eSS females showed the less 
severe kidney injury.  
No changes were observed in glomerular, tubular or interstitial structures of Wistar 
controls. 
4. Discussion and conclusions  
Most animal models develop mild renal lesions in early phase diabetes, but not advanced 
lesions in late phase and even in the best diabetic models, aging is a critical feature in the 
development of lesions typical of the human DN (Nakagawa, 2009). The relative long-life-
span of the eSS and eSMT rats, exceeding their metabolic disturbances, allowed the 
development of many of the characteristic lesions of diabetic nephropathy. This way, 
diabetic nephropathy worsened in both lines and sexes during the second year of life. 
Notwithstanding, results registered in 21-month-old control Wistar males demonstrated that 
ageing alone was unable to induce either a diabetic syndrome or diabetic renal lesions. It 
would also be argued that a particularly inherited liability of eSMT line might be an 
important single factor leading to a more severe renal injury.  If so, findings point out that 
diabetic nephropathy developed as the result of complex interactions between the 
background genome response, body weight, sex and long-standing metabolic disorders. 
Obesity is a very important factor in the beginning and rate of progression of metabolic 
disturbances and renal chronic complications of type 2 diabetes mellitus, in humans and in 
experimental models (Price et al., 2002; Nangaku et al., 2005). Even thought eSMT strain is 
not considered an obese model, these rats are more robust than eSS and this relative 
overweight has been considered a key factor in the generation of their earlier and more 
severe hyperglycaemia, hyperlipidaemia and hyperinsulinaemia (Tarrés et al., 2000; 
Montenegro et al., 2005; Picena et al., 2007). It is important to remark that eSS females, with 
the lowest body weight, had in turn the minor phenotypic diabetic expression. eSMT 
females, heavier than eSS females, displayed a more severe diabetic status and showed some 
glomerular alterations, as reduction in glomerulus’s diameter, similar to those found in eSS 
males.  
The degree and duration of hyperglycaemia constitute relevant risk factors regarding the 
occurrence and severity of renal impairment in people with both Type 1 (Alaveras et al., 
1997) and Type 2 Diabetes Mellitus (Ohkubo et al., 1995) as well as in induced diabetic 
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animal models (Kern & Engelman, 1990; Petersen et al., 1988). This way, the greater glucose 
metabolic disorder in eSS and eSMT males was clearly part of their more severe renal 
lesions. Several studies have pointed toward an association between sex hormones and the 
risk of Type 2 Diabetes Mellitus in men and women (Ding et al., 2006).  A study in the 
OLETF rats provided a strong support for this idea by showing that the incidence of Type 2 
Diabetes Mellitus was 100% in males and 0% in females (Shi et al., 1994).  The higher 
incidence and severity of nephropathy in Type 2 diabetic male patients and the opposite in 
women indicate that sex hormones impact in the development and progression of diabetic 
renal disease by mechanisms yet poorly understood (Maric, 2009). The influence of sex 
hormones over the eSS diabetic syndrome was studied in rats gonadectomized at 90 days of 
age (Tarrés et al., 1997). Spayed animals showed higher body weight, early and impaired 
intolerance to glucose and a decreased number of large pancreatic islets. Despite their lower 
biomass, castrated males did not evidence impairment in their intolerance to glucose, 
changes in insulinemia or remarkable modifications in endocrine pancreas histology. 
Further studies are needed for elucidating the complex interactions between genotype, body 
weight and sex in the onset of diabetes and the severity of chronic complications in the eSS 
and eSMT lines.  
Transforming growth factor-beta 1 (TGF-beta1) appears to be an important downstream 
mediator for the development of renal hypertrophy and the accumulation of mesangial 
extracellular matrix components (Ziyadeh & Wolf, 2008). In the OLETF rats, plasma TGF-
beta 1 and vascular TGF-beta type II receptors exist to a greater extent in pre- and early 
stages of diabetes mellitus when compared with non diabetic rats (Hosomi et al., 2002). 
Streptozotocin-induced type 2 diabetic rats fed a high fat diet developed a higher proportion 
of sclerosed glomeruli than type 1 diabetic rats and the expression of CTGF and TGF-beta 
was significantly increased, despite their lower blood glucose levels and proteinuria (Danda 
et al., 2005). The connective tissue growth factor (CTGF) is also overexpressed and involving 
in the pathogenesis of diabetic nephropathy; results from type 2 diabetic ob/ob mice 
demonstrated that albuminuria strongly correlated with urinary CTGF excretion 
(Roestenberg et al., 2006). The activated renin-angiotensin system (RAS) has been implicated 
in the acceleration of diabetic renal disease in type 2 diabetic OLETF rats, as indicated by the 
long-lasting renoprotective effects of temporary angiotensin II blockage during the 
prediabetic stage, independent of its effects on glucose metabolism  (Nagai et al., 2005). The 
observation that in the ZDF obese rats reactive oxygen species-associated angiotensinogen 
enhancement plays an important role in renal damage suggests that reactive oxygen species 
are partly involved in intrarenal angiotensinogen augmentation, leading to the development 
of diabetic nephropathy (Kobori et al., 2007).  
In summary, mechanisms underlying the development of diabetic nephropathy are 
extremely complex persisting unclear the nature of the relationship between diabetes and 
late-onset renal disease. Remain to be clarified whether genetic and environmental factors 
determining early stages of these disorders are independent from those controlling their 
progression (Brosius et al. 2009; Nobrega, 2009). 
The morphological changes in glomeruli of both strains were characterized by basement 
membrane thickening and diffuse mesangial expansion and, particularly in older eSMT 
males, by a diffuse or segmental glomerular sclerosis, being exceptional the nodular 
sclerosis of Kimmelstiel-Wilson. Moreover, it also shows that, even when the principal 
lesions affected the glomeruli according to the severity of glomerulopathy, the disease 
extended to the tubulointerstitial compartment. That morphological pattern has been 
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observed in Type 1 diabetic patients (Najafian et al., 2003) and in poorly controlled long-
term Type 2 Diabetes Mellitus, ascribed in the Category II of Fioretto et al.’s classification 
(2008). However, they also suffered from retinopathy, a nonexistent complication in eSS and 
eSMT rats.  
In congruence with Tervaert et al. (2010), most of eSS and eSMT animals less than 12-month-
old could be classified in Class I (barely evident mesangial lesions) whilst rats exceeding 12 
months of age could belong to Class II (diffuse mesangial glomerulosclerosis with moderate 
to severe expansion of mesangium). It is noteworthy to outline that although the naturally 
slower progress of the metabolic derangement in eSS males with respect to the eSMT, almost 
all males over 18 months of age in both lines could be classified as Class IV (advanced 
glomerulosclerosis). Even though, lesions compatible with Class III (nodular sclerosis or 
presence of one Kimmelstiel-Wilson nodule at least) were detected in only one 18-month-old 
eSMT male rat. This single finding makes it exceptional and fits with other spontaneous 
diabetic murine models (Yuzawa et al., 2008).  
It has been reported that nodular glomerulosclerosis is present in diabetic patients with 
more progressed clinical and pathological features (Jang & Park, 2009). Nevertheless, other 
authors have sustained that diffuse and nodular sclerosis could be two discrete patterns of 
glomerulopathy caused by different pathophysiological mechanisms as Kimmelstiel-Wilson 
lesion correlates with diabetic retinopathy but most of Type 2 diabetic patients without 
retinopathy develop diffuse mesangial sclerosis (Schwartz et al., 1998). Interestingly, no 
lesions of retinopathy have ever been detected in either eSS or in eSMT rats (Tarrés et al., 
1990; Tarrés et al., 2000; Picena et al., 2005). Moreover, although retinopathy and 
microalbuminuria are positively associated in Type 1 diabetic patients, the substantial 
discordances between glomerulopathy and retinopathy reported in Type 2 Diabetes Mellitus 
(Kanauchi et al., 1998; Boelter et al., 2006) highlights that kidney and retina are distinct 
organs with diverse underlying pathophysiologic mechanisms (Blum et al., 2011). Further 
studies on the eSS and eSMT lines rats could be useful for studying the aforesaid 
differences.  
Renal enlargement, particularly perceptible in eSMT males via the increase in kidney 
weights and diffuse mesangial expansion, evokes early stages of diabetic nephropathy.  
Notwithstanding, the areas of tubular atrophy detected in some eSS and particularly in the 
eSMT males at ~6 month, suggest a more advanced phase of diabetic nephropathy. 
Moreover, progression to macroalbuminuria and uremia already demonstrated in eSS male 
rats from  6 to 12 months of age in eSS males (Daniele et al., 2000), may be correlated with 
the increasing loss of glomerular filtration rate accompanying each nephron sclerosis during 
the progression of diabetic nephropathy.  While hyperglycaemia-induced osmotic polyuria 
has been implied as a relevant role in the onset and evolution of tubulointerstitial injury by 
causing an early tubular cell injury in the dilated collecting ducts (Wang et al., 2008), careful 
attention should be paid in the persistent glycosuria detected in eSS and eSMT rats 
(Martínez et al., 1988, Montenegro et al., 2005). Moreover, the differences found between 
diabetic rats and Wistar controls as well as between both diabetic lines in superficial and 
juxtamedullary glomeruli glucidic residues and in convoluted proximal tubules ones could 
be indicative of alterations in the filtration and in the intracellular tubular processes 
(Frontini et al., 2008).   
As suggested by Murata et al., 2002 in the Otsuka Long-Evans Tokushima Fatty (OLEFT) 
rats, we guess that the phenomenon of apoptosis could be operating at glomerular level in 
eSS and eSMT males which displayed a noticeable and increasing number of smaller 
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glomeruli as they get older. Furthermore, apoptosis induced by chronic hyperglycaemia has 
been related by Picena et al, (2007) with the dramatic reduction of the area of the islets of 
Langerhans described in older eSS males by Gomez Dumm et al., (1989). In diabetic 
nephropathy, the degree of proteinuria correlates with the progression of glomerulosclerosis 
and tubulointerstitial fibrosis (Wolf & Ziyadeh, 2007). The early albuminuria from 24-hs 
collections, the loss of glomerular filtration rate in 6-month-old eSS males and the 
progression to macroalbuminuria and uremia from 6 to 12 months of age (Daniele et al., 
2000), could be due to an increasing number of glomeruli affected associated to the 
progressive worsening of glucose and lipid disorders, particularly the rising values of 
hyperglycaemia, triglycerides, non-esterified fatty acids, total cholesterol,  and low-density 
lipoprotein cholesterol with high- density lipoprotein-cholesterol reduced, demonstrated in 
this strain at 12 month of age (Daniele et al., 2010). Previous studies in humans and animals 
have also suggested that altered lipid metabolism causes glomerular injury and promotes 
deterioration of glomerular function (Diamond & Karnovsky, 1987; Kasiske et al., 
1988; Maric et al., 2004).  
In humans, oxidative stress is linked to multiple chronic diabetic complications (Giacco & 
Brownlee, 2010). It is increasingly evident that changes in cellular function resulting in 
oxidative stress play a key role in the development and progression of diabetic nephropathy 
 (Forbes et al., 2008). Moreover, oxidized low density lipoprotein particles and non-esterified 
fatty acids could damage the mesangial cells and the tubulointerstitial tissue through 
different pathogenetic mechanisms (Nosadini & Tonolo, 2011). Interestingly, in 12 month-
old eSS rats increased basal glycaemia and fructosamine values correlate with those of lipid 
peroxidation substances and inversely with total antioxidant capacity (Daniele et al., 2007).  
In agreement with the data in diabetic patients and in other experimental diabetic models, 
and taking into account that hyperlipidaemia and oxidative stress have been syndicated as 
having major roles in the pathogenesis of the diabetic nephropathy (Kume et al., 2008), we 
suggest that early hyperinsulinemia and lipid disorders, already demonstrated in eSS rats 
(Montanaro et al., 2003. Daniele et al., 2010) and in eSMT rats (Tarrés MC et al., 2000) as well 
as the oxidative stress previously verified in eSS male rats (Daniele et al., 2007),  are key 
players in the development of the diabetic nephropathy in eSS and eSMT rats. Though new 
experiments could be undertaken in eSS and eSMT rats to brighten the genesis and 
evolution of their nephropathy, we conclude that these two spontaneously diabetic rats 
closely resemble the advanced human diabetic nephropathy and, simultaneously, have 
opened valuable opportunities for enhance our understanding about the interactions 
between glucose and lipid disorders and the pathways towards diabetic nephropathy, a 
relevant cause of morbidity and mortality in the diabetic population and the leading cause 
of end-stage renal failure in the Western World. 
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